NleC, a Type III Secretion Protease, Compromises NF-κB Activation by Targeting p65/RelA by Yen, Hilo et al.
NleC, a Type III Secretion Protease, Compromises NF-kB
Activation by Targeting p65/RelA
Hilo Yen
1, Tadasuke Ooka
2, Atsushi Iguchi
3, Tetsuya Hayashi
2,4, Nakaba Sugimoto
1, Toru Tobe
1*
1Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan, 2Division of Microbiology, Department of Infectious
Diseases, Faculty of Medicine, Frontier Science Research Center, University of Miyazaki, Miyazaki, Japan, 3Interdisciplinary Research Organization, Frontier Science
Research Center, University of Miyazaki, Miyazaki, Japan, 4Division of Bioenvironmental Science, Frontier Science Research Center, University of Miyazaki, Miyazaki, Japan
Abstract
The NF-kB signaling pathway is central to the innate and adaptive immune responses. Upon their detection of pathogen-
associated molecular patterns, Toll-like receptors on the cell surface initiate signal transduction and activate the NF-kB
pathway, leading to the production of a wide array of inflammatory cytokines, in attempt to eradicate the invaders. As a
countermeasure, pathogens have evolved ways to subvert and manipulate this system to their advantage.
Enteropathogenic and enterohemorrhagic Escherichia coli (EPEC and EHEC) are closely related bacteria responsible for
major food-borne diseases worldwide. Via a needle-like protein complex called the type three secretion system (T3SS), these
pathogens deliver virulence factors directly to host cells and modify cellular functions, including by suppressing the
inflammatory response. Using gain- and loss-of-function screenings, we identified two bacterial effectors, NleC and NleE,
that down-regulate the NF-kB signal upon being injected into a host cell via the T3SS. A recent report showed that NleE
inhibits NF-kB activation, although an NleE-deficient pathogen was still immune-suppressive, indicating that other anti-
inflammatory effectors are involved. In agreement, our present results showed that NleC was also required to inhibit
inflammation. We found that NleC is a zinc protease that disrupts NF-kB activation by the direct cleavage of NF-kB’s p65
subunit in the cytoplasm, thereby decreasing the available p65 and reducing the total nuclear entry of active p65. More
importantly, we showed that a mutant EPEC/EHEC lacking both NleC and NleE (DnleC DnleE) caused greater inflammatory
response than bacteria carrying DnleC or DnleE alone. This effect was similar to that of a T3SS-defective mutant. In
conclusion, we found that NleC is an anti-inflammatory bacterial zinc protease, and that the cooperative function of NleE
and NleC disrupts the NF-kB pathway and accounts for most of the immune suppression caused by EHEC/EPEC.
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Introduction
Enteropathogenic Escherichia coli (EPEC) and enterohemorrhagic
E. coli (EHEC) are worldwide causative agents of illness and death
[1]. EPEC causes infantile diarrhea, which is often lethal in
developing countries, and EHEC is a frequent cause of bloody
diarrhea and hemolytic uremic syndrome (HUS) even in
developed countries [2]. These pathogens are often transmitted
in contaminated food. Once they reach the human intestine, the
bacteria multiply and colonize on the mucosal surface. These
bacteria are also known as ‘‘attaching and effacing (A/E)’’
pathogens due to the histopathological lesions caused by the
intestinal colonization [3,4]. A/E lesions are characterized by
localized damage to the intestinal microvilli and the rearrange-
ment of host cytoskeletal proteins beneath the intimately attached
bacterial colonies [5,6].
The key virulence factors in A/E pathogens are encoded at the
locus of enterocyte effacement (LEE). The LEE, which is required
for the formation of A/E lesions during infection, encodes
regulators, an adhesin (intimin), chaperones, a translocator,
effector proteins, and type III secretion system (T3SS) components
[6]. In particular, the T3SS, an organelle common to the A/E
pathogens, is responsible for delivering bacterial effector proteins
directly from the bacterial cytoplasm into the host cytoplasm,
where they modify and disrupt host cell functions [6]. An isogenic
mutant defective in the T3SS loses the ability to establish
successful colonization on host cells, indicating that the T3SS is
a major determinant of pathogenicity [7,8]. In addition to the
seven effector proteins encoded by the LEE, EPEC and EHEC
possess a variety of effector proteins that are encoded elsewhere on
the genome. The EHEC genome encodes more than 40 effector
proteins [9]. and EPEC encodes at least 21 [10,11]. Although the
functions of several effector proteins have been reported, those of
many others have yet to be determined [12].
The intestinal epithelium plays an important role in generating
signals in response to pathogen infection to activate cells of the
innate and acquired immune systems present in the underlying
intestinal mucosa [13]. Mucosal inflammation is characterized by
the coordinated expression and up-regulation of a specific set of
gene products, including the cytokine and chemoattractant
interleukin (IL)-8, and macrophage inflammatory protein 1a
[14]. The NF-kB family proteins are key regulators of inflamma-
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include c-Rel, RelB, p65 (RelA), p50 (p105 processed form), and
p52 (p100 processed form) [15]. In unstimulated cells, homo- or
heterodimers of NF-kBs are maintained in an inhibited state in the
cytoplasm by their binding with IkB [16]. In an immune-
challenged state or during infection, stimulated Toll-like receptors
(TLRs) initiate a signaling cascade that results in activation of the
IkB kinase (IKK) complex [17,18]. The IKK complex phosphor-
ylates and ubiquitinates IkB, marking it for degradation, which
frees the NF-kB dimmers [15,19]. The dimers then enter the
nucleus and promote the transcription of genes for inflammatory
proteins such as IL-8, IL-1b, and TNF-a [20].
Over the course of EPEC or EHEC infection, the balance
between the pro-inflammatory bacterial extracellular components
and the proposed anti-inflammatory effector proteins shapes the
outcome of the host immune responses [21,22,23]. At the early
stage of infection, the NF-kB-mediated inflammatory response is
activated by T3SS-independent mechanisms; at later stages, the
response is repressed in a T3SS-dependent manner [18,19].
Several studies have indicated that flagellin is a major pro-
inflammatory mediator [20,21,22]; the detection of flagellin by
TLR-5 signals the activation of NF-kB to cause inflammation. On
the other hand, in differentiated Caco-2 cells infected by EPEC,
subsequent stimulation with TNF-a does not activate or cause the
nuclear translocation of NF-kB [18], and this inhibition is
independent of the LEE-encoded effectors [19]. Together, these
observations suggest that anti-inflammatory activity may be
mediated by non-LEE-encoded effector(s).
Recently, NleH and NleE have been shown to suppress host
NF-kB activation independently, through different mechanisms
[24,25,26]. NleH inhibits the translocation of ribosomal protein S3
(RPS3) into the nucleus, by binding to it in the cytoplasm, thereby
reducing the activation of NF-kB/RPS3-dependent promoters
[24]. A report on NleE elegantly demonstrated that NleE acts by
interfering with the activation of the IKK complex, thereby
maintaining the NF-kB dimers in an inhibited state [25].
However, unlike the T3SS-defective EPEC, the host immune
response shows residual repression when infected with the DnleH
or DnleE mutant of EPEC. This suggests the existence of an as-yet-
unidentified non-LEE effector protein(s).
In the present study, by using an artificially created,
reconstituted TOB02 strain (EPI300/LEE+BFP) that possesses
the LEE, bfp operon, and perABC regulators of EPEC, and a series
of EPEC deletion mutants, we have identified NleC as a novel
effector that suppresses NF-kB activation. We determined that
NleC acts by directly cleaving the NF-kB subunit p65 to a form
that is degraded by proteasomes. We also showed that an EPEC
compound mutant lacking both NleC and NleE was less effective
at suppressing NF-kB activation than EPEC deficient in either
gene alone (DnleC or DnleE). Furthermore, infection with the
double mutant of EHEC or EPEC leaves the host response toward
inflammatory stimulants nearly intact, at the level seen with a
T3SS-defective strain.
Results
Characterization of a reconstituted bacterium possessing
the LEE and bfp operon
To evaluatetheeffect ofindividualnon-LEE effectorsonhost-cell
immune responses, we employed a reconstituted Escherichia coil K12
strain that carries two plasmids, one harboring the full LEE locus
and the other bearing a bfp operon for the bundle-forming pilli and
the perABC regulatory genes of EPEC B171-8 (hereinafter referred
to as TOB02) (Fig. S1). The LEE locus encodes the injectisome of
the type III secretion (T3S) apparatus and essential virulence factors
such as Tir and Intimin, which are necessary for intimate
attachment, a hallmark of the EPEC/EHEC adherence [2]. To
confirm that TOB02 was capable of colonization and establishing
intimate attachment, we infected HeLa cells with it and looked for
the reorganization of F-actin beneath the attached bacteria, a
characteristic result of the intimate attachment that is dependent on
virulence factors encoded by LEE. Following the infection, the cells
were stained with DAPI and Rhodamine-phalloidin. Similar to
infections of EPEC, microcolonies formed within 30 min of the
infection, and an intense accumulation of F-actin was observed
beneath the bacterial colonies (Fig. 1A). To confirm that the
reconstituted TOB02 bacterium expressed a functional T3S system
(T3SS), we assayed the secretion of a LEE-encoded protein, EspB,
which is secreted through the T3SS [25]. We probed the culture
supernatant of the TOB02 cells with an anti-EspB antibody, and
detected EspB in an immunoblot (Fig. 1B). In addition, we also
compared the amountofTirtranslocated into host cellsbetween the
native EPEC and TOB02 strains (Fig. S2). Taken together, these
results indicate that the T3SS of TOB02 is functional and that this
strain can establish an intimate attachment to epithelial cells.
We next analyzed the inflammatory response of host cells upon
TOB02 infection. As reported previously, the detection of PAMPs
(pathogen-associated molecular patterns) by TLRs on the cell
surface triggers the inflammatory response, which is suppressed by
EPEC/EHEC during the early stage of colonization. Because
T3SS-defective EPEC/EHEC cannot suppress the host immune
response, the suppression of the host inflammatory response has
been proposed as a T3SS-dependent phenomenon [22,23], and
therefore effectors on the LEE locus or non-LEE loci have been
predicted to downregulate the host immune responses following
the T3SS injection [22,23]. To compare the response between
cells infected with TOB02 and wild-type EPEC, we infected HeLa
cells with TOB02 or with wild-type EPEC strains E2348/69 and
B171-8 and their DT3SS mutants (E2348/69 DescF and B171-8
DescC). Following the infection, the cells were stimulated with heat-
killed E. coli (HKE), and the amount of secreted IL-8 was
measured. We found that cells infected with TOB02 released a
Author Summary
Enteropathogenic Escherichia coli (EPEC) and enterohe-
morrhagic E. coli (EHEC) cause food-borne diseases,
including watery diarrhea or severe bloody diarrhea and
life-threatening kidney disease (hemolytic uremic syn-
drome). Upon ingestion, EPEC/EHEC colonize the cells of
the epithelial lining in the intestinal tract. In response, the
affected cells initiate an immune response by secreting
cytokines that attract immune cells. To prevent their early
elimination by the host, these bacteria have developed
strategies to prevent the host immune response. They do
this by injecting bacterial effectors into the host cells to
disrupt the NF-kB pathway, an essential effector of the
host cell immune response. In the current study, we report
the discovery of an NF-kB suppressive effector in EPEC/
EHEC called NleC, and its novel mechanism. We found that
NleC is a zinc protease that can digest p65, a critical
component of the NF-kB pathway, thus dampening the
host inflammatory response. NleE is another recently
identified anti-inflammatory effector. We show here that
an EPEC/EHEC mutant deficient in both NleC and NleE
loses most of its ability to suppress the host inflammatory
response. Our findings show how two different bacterial
effectors can function in cooperation to modify the host
immune response.
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LEE-encoded effectors, the lack of a marked reduction in the
inflammatory response of the TOB02-infected cells indicated that
effectors residing on the LEE locus may not be very important in
the host inflammatory suppression. Therefore, we used the
TOB02 strain to determine which effectors on non-LEE loci
could cause reduced immune responses upon infection.
NleC reduced the inflammatory response by inhibiting
NF-kB signaling
Since EPEC and EHEC are closely related pathogens that
suppress host immune responses [22,23], we postulated that the
T3SS-dependent anti-inflammatory effector proteins might be well
conserved between these pathogens. We therefore compared the
repertoires of the T3SS-dependent non-LEE effector proteins of
EPEC (E2348/69 and B171-8) [10,11] and EHEC (O157:H7
Sakai, O26, O111, O103) [9,27,28], and established strains of
TOB02 carrying each of these shared non-LEE-effector genes
(espF, espG, espJ, espK, espO, espZ, Map, nleA, nleB, nleF, nleH1, nleG,
nleC, nleE, and espH). HeLa cells were infected with each strain
followed by stimulation with HKE, and the IL-8 released into the
medium was measured. Strains that caused a significantly lower
secretion of IL-8 in comparison with the empty-vector control
(TOB02/HA) were considered effective. Using this method, we
identified NleC and NleE as effectors that could greatly decrease
IL-8 secretion by the host cells (Fig. 2A).
Recently, Nadler et al. and Newton et al. reported that NleE
blocks NF-kB signaling by inhibiting TAK1/IKK activation
[25,26]. Thus, the identification of NleE using the TOB02 system
supported the validity of our screening method. We therefore
focused on analyzing NleC. We first confirmed the secretion of
NleC-HA by TOB02/nleC-HA (Fig. S3). Because IL-8 is a
downstream target of the activated NF-kB pathway, we used an
NF-kB reporter assay to verify that TOB02/nleC-HA could
interfere with the NF-kB signaling cascade. HeLa cells transfected
with reporter plasmids that harbored a NF-kB-regulated SEAP
Figure 1. TOB02 is a functional tool for studying the effects of
individual effectors. (A) Induction of actin polymerization by
infection with TOB02. HeLa cells were infected with TOB02 for 3 hours.
The cells were then fixed with 4% PFA and stained with Rhodamine-
Phalloidin (red) and DAPI (blue). Arrow indicates the location of
bacterial attachment. (B) Secretion of LEE-encoded virulence factor by
TOB02. Overnight-grown TOB02 was inoculated and cultured in fresh
DMEM until O.D600 ,1.0. The cell pellet (Whole cell) and culture
supernatant (Supernatant) were collected and analyzed with anti-EspB
and anti-DnaK antibodies. (C) Cellular response to infection with
reconstituted strains. HeLa cells were infected with TOB02, E2348/69 WT
(EPEC wild type), E2348/69 DescF (DT3SS), B171-8 WT (EPEC wild type),
and B171-8 DescC (DT3SS) for 3 hours. Then cells were rinsed and
incubated in fresh DMEM containing 0.1 mg/ml gentamicin and heat-
killed bacteria (HKE) (10
8/ml). Cells were further cultured for 8 hours,
and the culture supernatants were analyzed for IL-8 by ELISA. Negative
and positive controls were non-infected/non-stimulated (N.I/N.S) and
non-infected/stimulated (N.I/S) cells, respectively.
doi:10.1371/journal.ppat.1001231.g001
Figure 2. NleC can inhibit NF-kB activation. Two days prior to
infection, HeLa cells were transfected with NF-kB and Luciferase
reporter plasmids. On the day of infection, HeLa cells were infected with
various bacterial strains for 3 hours. The medium was replaced with
fresh DMEM containing gentamicin and HKE. The cells were further
cultured for 8 hours, then the IL-8 or reporter activities of NF-kB and
Luciferase were determined. The positive and negative controls were
non-infected/non-stimulated (N.I/N.S) and non-infected/stimulated (N.I/
S) HeLa cells. In the reporter assays, the NF-kB activity was normalized
to the luciferase activity. All experiments were performed in triplicate
and repeated three times. Representative results from the repeated
experiments are shown. Significance was calculated by student’s t-test,
where p,0.05 was considered significant. (A) IL-8 secretion by cells
infected with an nleC- or nleE-expressing strain. Cells were infected with
TOB02/HA (HA), TOB02/nleF-HA (nleF), TOB02/nleC-HA (nleC), or TOB02/
nleE-HA (nleE). IL-8 was analyzed by ELISA. (* p,0.05, compared to HA).
(B) NF-kB activation in cells infected with an nleC-expressing strain. Cells
were infected with TOB02/HA or TOB02/nleC-HA (nleC). (* p,0.05,
compared to HA) (C) NF-kB activity in cells infected with EPEC mutants.
For infection, wild-type EPEC (WT), a DT3SS mutant (DescF), and a series
of isogenic mutants was used: A1 (deletion of IE2 region), A2 (A1 plus
PP2 region deletion), A3 (A2 plus PP4 region deletion), A4 (A3 plus IE6
region deletion), A5 (A4 plus PP6 region deletion), A6 (A5 plus IE5
region deletion), and A7 (A6 plus espG deletion). (* p,0.05, compared
to WT) (D) NF-kB activity in cells infected with an EPEC mutant
expressing non-LEE effectors. Cells were infected with wild-type EPEC
(WT), DT3SS mutant (DescF), A4, or A4 harboring a plasmid with nleB
(A4/nleB), nleE (A4/nleE), espL (A4/espL), or nleC (A4/nleC). (* p,0.05,
compared to A4).
doi:10.1371/journal.ppat.1001231.g002
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either TOB02/HA or TOB02/nleC-HA. After 3 hours of
infection, the cells were further stimulated with HKE and assayed
for the NF-kB reporter activity. As shown in Figure 2B, the NF-kB
activity in the cells infected with TOB02/nleC-HA was significantly
lower than in the cells infected with TOB02/HA. These results
suggested that NleC suppressed the NF-kB activation, which led to
the reduced secretion of IL-8 by the host cells.
EPEC mutants lacking multiple effector gene loci lost
most of their suppression activity
In our effort to screen for potential immune-suppressive non-
LEE effectors, we devised another system using a series of EPEC
mutants. These mutants, designated TOE-A1 to -A7, were
designed to lose a cluster of effector genes in each specific
horizontally transferred element (IE: integrative element, and PP:
prophage) in a step-wise and additive fashion (Table S1). We used
this approach to identify effectors with similar anti-inflammatory
effects. We infected HeLa cells with these mutants, and the activity
of the NF-kB reporter was determined after stimulating the cells
with HKE. In this experiment, TOE-A4 lost most of the host
immune suppression activity (Fig. 2C). TOE-A4 was derived from
TOE-A3 by the deletion of a cluster of effector genes in IE6, which
contains three effector genes, nleE, nleB1, and espL. Thus, TOE-A4
lacked nine effector genes (nleB2, nleH1, espJ, nleG, nleC, nleD, nleE,
nleB1, and espL: Table S1). Since NleE is required but insufficient
for the full repression of NF-kB activation by EPEC, additional
effectors were predicted to be involved [25]. Furthermore, host
cells infected with TOE-A5 to -A7 did not show a significantly
greater recovery of their NF-kB activity than cells infected with
TOE-A4 or DescF mutant, suggesting that none of the non-LEE
effector proteins besides the ones missing from TOE-A4
contributed significantly to the disruption of the NF-kB signaling
cascade. In another words, the full de-repression of the NF-kB
activity by EPEC can be attributed to the combined loss of NleE
and one or more of the protein(s) missing from the TOE-A4
mutant.
From our primary screening with the TOB02 system, we ruled
out nleH1, espJ, nleG, nleD, espL,o rnleB, because they were unable
to suppress the host inflammatory response to HKE (data not
shown). Therefore, we examined EPEC TOE-A4 harboring an
nleC-expressing plasmid for the ability to suppress NF-kB activity.
We found that TOE-A4/nleC restored the suppression of the host
NF-kB activity to a level near that achieved with TOE-A4/nleE or
wild type (Fig. 2D). Taken together, our results strongly indicated
that NleC is an immune suppressor with activity comparable to
NleE in a complementary setting that may act in parallel to or be
redundant with NleE.
Repression of NF-kB activation by NleC was independent
of other bacterial factors
To determine whether the function of NleC required other
bacterial co-factors, we constructed a mammalian expression
vector bearing a fusion protein, eGFP-NleC, and introduced it
into HeLa cells together with the NF-kB reporter plasmid. After
stimulating the cells with HKE, the reporter activities were
determined. As shown in Figure 3A, whereas the non-transfected
(NF-kB reporter plasmid only) and empty-vector controls showed
high NF-kB activity in response to the HKE stimulation, the
eGFP-NleC-expressing HeLa cells showed markedly lower NF-kB
activation. Taken together, these results suggested that NleC is a
negative regulator of the host NF-kB signaling pathway, and that it
does not require bacterial co-factors for its function.
The NF-kB signaling cascade is divided mainly into cytoplasmic
and nuclear portions [15]. To elucidate where NleC functions to
interfere with this cascade, we examined its localization after being
injected into host cells via T3SS. After 3 hours of infection with
TOB02/nleC-HA, the cells were fixed and stained with anti-HA/
anti-mouse IgG-FITC, Rhodamine-Phalloidin, and DAPI. Most
of the NleC-HA was apparently in the cytoplasm, although the
strongest signals were observed beneath the microcolonies
(Fig. 3B). We also found that NleC-HA showed the same
distribution pattern in host cells infected with wild-type EHEC,
via the endogenous T3SS (Fig. S4). These results suggested that
NleC targets one or more cytoplasmic factors in the host NF-kB
pathway.
NleC decreased the p65 protein level in the host cell
Since NleC was determined to be predominantly cytoplasmic,
and since various upstream signals converge to modify the IkBa/
p65/p50 complex, which serves as a signaling hub, we decided to
first examine changes that might occur at this complex. To do this,
HeLa cells were infected with either TOB02/HA or TOB02/nleC-
HA bacteria. After 3 hours of infection, the HeLa cells were
further stimulated with HKE for 20 and 40 min, before being
collected for western blot analysis. Using antibodies specific to the
N-terminal region of p65 (p65 N-term), phospho-p65, and IkBa,
we detected a significant down-regulation of p65 in cells infected
with TOB02/nleC-HA (Fig. 3C). Compared to the level in cells
infected with TOB02/HA, the amount of total p65 as well as the
phospho- (active) p65 was lower in the TOB02/nleC-HA-infected
cells even before the HKE stimulation. These results suggested
that NleC may either directly or indirectly target p65 to decrease
NF-kB signaling.
Based on this result, we speculated that NleC promotes the
degradation of p65 in the cytoplasm. The ubiquitination-
proteasome pathway is involved in selective protein decomposi-
tion, and several studies have shown that p65 is poly-ubiquitinated
and targeted for proteasomal degradation [29,30,31,32]. We
therefore tested whether MG132, a reversible inhibitor of
proteasomes, could prevent the p65 degradation in the presence
of NleC. HeLa cells pretreated with either DMSO or MG132
(5 mM) were infected with TOB02/HA or TOB02/nleC-HA for
3 hours. As shown in Figure 3D, using the p65 N-terminal specific
antibody, we found that the total p65 decreased substantially
regardless of DMSO or MG132 treatment in the TOB02/nleC-
HA infected cells.
Next, we used a C-terminal-specific antibody to detect p65,
which at first glance confirmed the reduction of the protein.
However, upon closer examination, we noticed a smaller fragment
in addition to the full-length p65 that was specific to the TOB02/
nleC-HA-infected cells (Fig. 3D; middle panel). Moreover,
treatment with MG132 or lactacystin resulted in an accumulation
of this smaller fragment (Fig. S5). This observation suggested that
NleC may be directly or indirectly involved in generating this
cleaved product, which is targeted for proteasomal degradation.
Thus, our findings strongly suggest that NleC injection could
trigger the reduction of NF-kB activity by decreasing the amount
of p65 in infected cells.
NleC directly cleaved p65 at its N-terminal domain
Since the smaller p65 (hereafter referred to as p65-C) could only
be detected by the C-terminal-specific antibody, and the size
difference between the full-length and cleaved form differed by
only several kiloDaltons, we predicted that the cleavage site would
be located at N-terminus. To determine the actual cleavage site,
we extracted p65-C and analyzed its amino acid sequence from
NleC Cleaves p65/RelA
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matched the 11th to 14th residues of the full length p65.
Therefore, we concluded that the cleavage occurs between the
10th and 11th amino acid of p65. Coiras et al. reported that
activated caspase-3 can mediate the cleavage of p65 at its N-
terminal region to generate a C-fragment in non-apoptotic T-
lymphocytes [33]. To examine the possible involvement of
caspase-3 in the cleavage of p65 in cells infected with nleC-
expressing bacteria, we pretreated HeLa cells with either DMSO
or z-VAD-fmk (a pan-inhibitor of caspase). However, the
inhibition of caspase-3 activity with z-VAD-fmk did not affect
the generation of p65-C (Fig. S6).
To elucidate the relationship between NleC and p65-C, we
carried out in vitro cleavage assays to recapitulate the observation
made in TOB02/nleC-HA-infected HeLa cells. We constructed
and purified a fusion protein of NleC with GST attached to its N-
terminal end (GST-NleC). To confirm the activity of the purified
protein, cell lysates prepared from unstimulated HeLa cells were
incubated with the purified GST-NleC. Using N- and C-terminal-
specific antibodies to p65, we detected a decrease in p65 and the
appearance of p65-C only in the mixture containing GST-NleC
(Fig. 4A).
Next, to determine the dependency of this cleavage on host co-
factors, purified p65 was mixed with GST-NleC. While both the
p65 only and GST-added control samples showed no change in
total p65 nor the detection of p65-C, the GST-NleC-containing
mixture had less p65, and p65-C was readily detected (Fig. 4B).
Based on these observations, we concluded that NleC could
mediate the direct digestion of p65.
We next performed a bioinformatic search for any known
domains in NleC. The search predicted a zinc protease domain
located between amino acids 183 and 187. This amino acid
sequence, HEIIH, corresponds to the consensus sequence HExxH,
where x is any amino acid. To test if this domain was responsible
for mediating the cleavage of p65, we performed site-directed
mutagenesis in which we replaced the second histidine with
tyrosine (H187Y) (Fig. 4C). Since both histidines of HExxH come
in contact with zinc ions, the mutation of either residue should
disrupt the domain and render it non-functional [34]. We mixed
purified p65 with GST, GST-NleC wild type (GST-NleC), or
GST-NleC mutant (GST-NleCmut) in vitro. As shown in
Figure 4D, although GST-NleC produced p65-C, GST-NleCmut
did not. Moreover, 10 mM EDTA greatly impeded the function of
GST-NleC, suggesting that divalent metal cations are necessary
for its activity (Fig. 4D).
Figure 3. NleC interferes with NF-kB activation by downregu-
lating p65. (A) NF-kB activity in cells transfected with nleC. HeLa cells
were all transfected with NF-kB and luciferase reporter plasmids. In
addition, either eGFP plasmid (Empty vector) or eGFP-NleC-expressing
plasmid was introduced into the cells. ‘‘Non-transfected’’ indicates cells
transfected with only the reporter plasmid. Two days post-transfection,
the cells were stimulated with HKE. The culture medium and cell lysates
were then analyzed for NF-kB SEAP and Luciferase activity. (* p,0.05,
compared to stimulated Empty Vector). (B) Localization of NleC in
infected cells. HeLa cells were infected with either TOB02/HA or TOB02/
nleC-HA. After 3 hours of infection, cells were washed and fixed with 4%
PFA, then stained with anti-HA (FITC), phalloidin (red), and DAPI (blue).
(C) Decrease in the IkBa and p65 proteins in cells infected with the nleC-
expressing strain. HeLa cells were infected with TOB02/HA (HA) or
TOB02/nleC-HA (nleC-HA). After 3 hours of infection, the cells were
rinsed and incubated in fresh DMEM containing 0.1 mg/ml gentamicin
and a 1/10 volume of HKE. HKE stimulation proceeded for 20 and
40 min, and cells were collected for western blot analysis. Cell extracts
were probed with anti-p65 (N-term.), anti-phospho-p65, anti-IkBa, and
anti-a-tubulin (as a loading control) antibodies. Non-infected/Non-
stimulated cells at 0 min. (N.I/N.S at 0 min.) served as a negative
control. Non-infected/stimulated (N.I/S) cells at 20 and 40 min were
positive controls. (D) Appearance of a cleaved fragment of p65 in cells
infected with the NleC-expressing strain. Two hours prior to infection,
HeLa cells were pretreated with either DMSO or MG132 (5 mM). The cells
were infected with TOB02/HA (HA) or TOB02/nleC-HA (nleC-HA) for
3 hours. The cells were then rinsed and lysates were prepared for
analysis. Anti-p65 antibodies specific to either the N- or C- terminal
regions were used. Non-infected (N.I) cells served as a negative control.
doi:10.1371/journal.ppat.1001231.g003
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protease domain and the protease activity of NleC in the NF-kB
suppression.HeLa cells were infected with TOB02/HA, TOB02/nleC-
HA, or TOB02/nleCmut-HA for 3 hours, stimulated, and then reporter
activities measured. As shown in Figure 4E, whereas TOB02/nleC-HA
significantly suppressed the NF-kB activation, TOB02/nleCmut-HA
failed to do so, indicating that the mutant had lost the anti-
inflammatory effect of intact NleC. Taken together, these results
showed that the HEIIH region of NleC is a zinc protease domain
necessary for cleaving p65 and suppressing the host NF-kB activity.
NleC functions in wild-type EPEC- and EHEC-infected cells
Using the reconstituted TOB02/nleC-HA strain, we discovered
that NleC functions in host cells as a p65-targeting enzyme. Since
the expression of nleC in the TOB02 strain is activated through an
IPTG-inducible promoter, we wanted to know if we could observe
a similar enzymatic activity when NleC was at its physio-
pathologically relevant level, in infections with native strains of
EPEC or EHEC. Therefore, we infected HeLa cells with wild type
(WT), DnleC,o rDnleC/nleC-HA EPEC for 2 h, and analyzed the
amount of cytoplasmic and nuclear p65 in the cells using an anti-
p65 (N-terminus) antibody after treatment of cells with HKE. We
observed a reduction in cytoplasmic p65 in the WT-infected cells
compared to cells infected with the DnleC mutant strain (Fig. 5A;
left panel). As for nuclear p65, the amount of p65 was significantly
reduced in both wild type and DnleC mutant infected cells
compared to that of DescF (Fig. 5A; right panel). Next, we also
analyzed the appearance of p65-C fragment in wild type-infected
cells. When p65 in total lysate was detected using anti-p65 (C-
term), we identified the generation of p65-C fragment in wild type
Figure 4. NleC cleaves p65 by its zinc protease domain. (A) Activity of purified GST-NleC protein. For lysates, 1610
6 of unstimulated HeLa cells
were lysed by NET150 (10 mM Tris-Cl pH 8.0, 0.5% Triton-X100, 150 mM NaCl, 10% glycerol) without EDTA or protease inhibitors. GST protein or GST-
NleC protein expressed in bacteria was purified and mixed with the HeLa lysates. The reaction mixtures were incubated at 25uC for 8 hours and then
analyzed with antibodies against p65 (N-terminal or C-terminal specific) and a-tubulin (as a loading control). (B) Cleavage of p65 by NleC alone. p65,
GST, and GST-NleC were expressed in bacteria and purified. The p65 was then mixed with either GST or GST-NleC in the reaction buffer. The mixtures
were incubated at 25uC for 8 hours and analyzed with anti-p65 (N-term.) and anti-p65 (C-term.) antibodies. (C) Zinc protease motif in NleC. Schematic
diagram showing the zinc protease domain in NleC. A Histidine (H) at 187 was replaced with Tyrosine (Y) by site-directed mutagenesis. (D) NleC’s
cleavage activity required the zinc protease motif and divalent metal ions. p65, GST, GST-NleC wild type (GST-NleC), and GST-NleC mutant (GST-
NleCmut) were expressed in bacteria and purified. The p65 was mixed with GST, GST-NleC, or GST-NleCmut in the reaction buffer. The cleavage
reaction was performed at 25uC for 8 hours. Samples were analyzed with anti-GST and anti-p65 antibodies against either the N- or C-terminal region.
For the EDTA inhibition, EDTA was included in the reaction buffer at a final concentration of 10 mM. (E) NF-kB activity in cells infected with the
nleCmut-expressing strain. Two days prior to infection, HeLa cells were transfected with NF-kB and luciferase reporter plasmids. Forty-eight hours
post-transfection, cells were infected with TOB02/HA, TOB02/nleC-HA (nleC), or TOB02/nleCmut-HA (nleCmut) for 3 hours. Cells were rinsed and
incubated in fresh DMEM containing 0.1 mg/ml gentamicin and HKE (10
8/ml). Cells were stimulated for 8 hours, then the medium and cell lysates
were analyzed for NF-kB SEAP and Luciferase reporter activities. Non-infected/non-stimulated (N.I/N.S) and non-infected/stimulated (N.S/S) HeLa cells
served as negative and positive controls, respectively.
doi:10.1371/journal.ppat.1001231.g004
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strains (Fig. S7). Taken together, we showed that NleC also
functions as a protease targeting p65 in native strains. These
results suggested that, even when NIeC was at physio-pathological
levels, it could cleave p65, although the effect was less profound
than that of the nleC complemented strain, presumably due to the
difference in the amount of NleC present in the host cells.
The EPEC DnleC DnleE compound mutant of EPEC and
EHEC caused little reduction of NF-kB activation
After determining that NleC was an anti-inflammatory effector
and identifying its functional zinc protease domain, we next
examined whether NleC contributes to the immune suppression
by EPEC/EHEC. For this, we generated an equivalent set of
mutant strains in EPEC and EHEC, and measured the IL-8
secretion of cells infected with the EPEC/EHEC mutant. As
shown in Figure 5B, the DnleC mutant of EPEC showed a
comparable suppressor activity to the wild type EPEC. On the
other hand, we observed statistically significant elevation of IL-8
secretion from the DnleC mutant of EHEC-infected cells compared
to the WT EHEC-infected ones. We also infected HeLa cells with
the DnleE mutant of EPEC and EHEC and observed increased IL-
8 secretion, which is in agreement with the reported results of
EPEC: nleE by Nadler et al and Newton et al [25,26].
Although the IL-8 response by the host cells after the DnleC or
DnleE mutant challenges was better, the inflammatory response
was still only partial compared to that permitted by the DescF or
DescD mutant. Based on the proposed actions of NleE and NleC as
negative regulators of IKK activation and homeostasis of p65,
respectively, and the observation that full host NF-kB activity was
preserved during infection with TOE-A4, we predicted that NleE
and NleC contributed the major portion of the suppression of
pathogen-induced activation of NF-kB pathway. We therefore
analyzed the total IL-8 secreted from HeLa cells infected with the
DnleC DnleE (double knock-out) mutant. As shown in Figure 5B
and 5C, whereas the wild type substantially inhibited the IL-8
secretion in infected cells, the infection of isogenic DnleC DnleE
compound mutant resulted in a significantly diminished inhibition
of IL-8 secretion compared to WT. Furthermore, the level of the
IL-8 response exhibited by host cells infected with the compound
mutant was comparable to that of cells infected by the T3SS
defective mutant (DescF of EPEC and DescD of EHEC). The
introduction of the nleCwt but not nleCmut expression plasmid into
the DnleC DnleE mutant effectively restored the inhibition of IL-8
secretion by the infected cells. This major de-repression of the host
NF-kB activation in the DnleC DnleE mutant suggested that these
two T3SS-dependent, non-LEE effector proteins function in
concert for the suppression of the NF-kB-signaling cascade and
that the zinc protease domain is necessary for the anti-
inflammatory function of NleC (Fig. 6).
Discussion
Bacterial antigens of infecting pathogens can trigger intense
local inflammation and the mobilization of immune cells. To
Figure 5. Concurrent deficiency in nleE and nleC impedes the
immune-suppressive ability of EPEC/EHEC. (A) Amount of
cytoplasmic and nuclear p65 protein in cells infected with nleC mutants.
HeLa cells were infected with EPEC wild type (WT), DescF mutant, DnleC
mutant, and DnleC/nleC complemented strains for 2 hours. At the end
of the infection, TNF-a (50 ng/ml) was added, and the cells were further
cultured for 40 min before being collected. The cytoplasmic and
nuclear fractions were analyzed by anti-p65 (C-term.), anti-Lamin A/C
and a-tubulin antibodies. This experiment was repeated three times
and one of the representative blot is shown. For quantification, the total
cytoplasmic p65 and the total nuclear p65 were normalized to the a-
tubulin and Lamin A/C using ImageJ software. NI/NS (Non-infected/
Non-stimulated) and NI/S (Non-infected/Stimulated) served as the
negative and positive controls for p65 translocation in response to
the TNF-a stimulation (* p,0.05, compared to cytoplasmic NI/NS;
** p,0.05, compared to nuclear NI/S). (B) IL-8 secretion by cells infected
with EPEC or EHEC mutants. HeLa cells were infected with wild type,
DT3SS mutant (DescF for EPEC; DescD for EHEC), DnleC, DnleE, and
DnleC DnleE of EPEC and EHEC. Infections were proceeded for 3 hours
for EPEC and 4 hours for EHEC strains. Cells were then rinsed and
incubated in fresh DMEM containing 0.1 mg/ml gentamicin and HKE.
Culture medium were collected 8 hours of stimulation and amount of
IL-8 analyzed by ELISA. Non-infected/non-stimulated (N.I/N.S) and non-
infected/stimulated (N.I/S) cells served as negative and positive controls
(* p,0.05, compared to WT). Values of DnleC DnleE double KO mutant
are not significantly different from DT3SS (p.0.05). (C) IL-8 secretion by
cells infected with EHEC compound mutants. HeLa cells were infected
with wild-type EHEC (WT), DT3SS mutant (DescD), DnleC DnleE mutant,
or DnleC DnleE mutant harboring nleCwt or nleCmut plasmid for
4 hours. The cells were then rinsed and incubated in fresh DMEM
containing 0.1 mg/ml gentamicin and HKE. After 8 hours of HKE
stimulation, the culture supernatants were collected and analyzed for
IL-8 by ELISA. Non-infected/non-stimulated (N.I/N.S) and non-infected/
stimulated (N.I/S) cells served as negative and positive controls.
(* p,0.05, compared to DnleC DnleE).
doi:10.1371/journal.ppat.1001231.g005
NleC Cleaves p65/RelA
PLoS Pathogens | www.plospathogens.org 7 December 2010 | Volume 6 | Issue 12 | e1001231prevent their early elimination, the EPEC and EHEC A/E
pathogens control the host response by delivering anti-inflamma-
tory bacterial proteins into the host cells. Although the recent
identifications of NleH1 NleE and NleB showed that EPEC/
EHEC use different mechanisms to modify the host immune
response [24,25,26], those mechanisms did not completely
account for the full immune-suppressive potential of these
pathogens. Here, we found that NleC of EHEC and EPEC
negatively modulates the host inflammatory response by reducing
the amount of the mammalian p65 subunit of NF-kB. Specifically,
this reduction is due to the direct cleavage of p65 by NleC,
followed by proteasomal degradation of the cleaved p65. We also
demonstrated that two type III secretion effectors, NleC and NleE,
are necessary for and function in cooperation to achieve most of
the immune suppression caused by these pathogens. By combining
these effectors, EPEC and EHEC efficiently inhibit the activation
of the NF-kB signaling pathway in infected host cells, thereby
weakening the inflammatory response.
With the aim of discovering putative anti-inflammatory T3SS-
dependent, non-LEE-encoded effector proteins, we employed both
gain-of-function and loss-of-function approaches. In the gain-of-
function analysis, we used a reconstituted bacterial system to study
the effect of individual effector proteins on the host innate immune
response. This method is preferable to transfection, because these
artificial A/E bacteria bearing selected non-LEE effector genes
faithfully recapitulated the infection and colonization of host cells
in a T3SS-dependent manner. Moreover, because they expressed
BFP, the reconstituted strain established colonies as quickly and
efficiently as wild-type EPEC. As a result, the pathological action
of the effectors could be compared over a similar time course with
that of the native A/E pathogens. Another reason we avoided
using transfection is that the expression levels may vary from cell
to cell, and the transfection efficiency is difficult to maintain at a
high level for all candidate genes, leading to possible false read-
outs. Finally, the reconstitution method is also appropriate for
isolating effectors with redundant functions. However, since
amount and stability of translocated effector can not be controlled
to be the same level, we can not rule out the presence of other
effector(s) involving in modulation of inflammatory response by
only this screening. Nevertheless, the use of this reconstituted
system revealed not only NleC as a novel anti-inflammatory factor,
but also the already-reported NleE [25,26].
In the loss-of-function analysis, we used a set of EPEC mutant
constructs with serial deletions of the pathogenic islands. This
approach allowed the identification of multiple cooperative
effectors that may have similar functions. Using this series of
deletion mutants, we identified the EPEC mutant TOE-A4, which
lacked four horizontally transferred elements that included nine
non-LEE effector genes, and was as incapable of inhibiting NF-kB
activation as the T3SS-deficient mutant. This complete loss of
immune suppressing activity was also seen when NleE-NleB were
deleted from TOE-A3. In contrast, Nadler et al. showed only a
partial alleviation of the suppressed host inflammatory response
using an EPEC DnleE DnleB double mutant [25]. The inconsis-
tency between our findings in TOE-A4 and theirs may lie with the
genes that had already been deleted from TOE-A3. Because we
ruled out espJ, nleF, nleG, nleH1, nleD, espL, and nleB, based on our
primary screening using the TOB02 strains, we speculate that the
effectors responsible for most of the immune-suppressive effect
exerted by EPEC or EHEC in response to HKE are NleC and
NleE. Indeed, we showed that compound EPEC and EHEC
mutants lacking both NleC and NleE (DnleC DnleE) were incapable
of suppressing the host IL-8 secretion to a similar degree as the
DT3SS (DescF) mutant after being stimulated with HKE, which
engaged and activated mainly TLR-/IL-1b -NF-kB signaling
pathways. The introduction into this compound mutant of either
an nleC-o rnleE- expressing plasmid restored the mutant’s ability to
suppress NF-kB activation. On the other hand, NleH1, another
reported anti-inflammatory effector was not identified in these
screenings. For verification, we generated an EHEC mutant
deficient in NleH1 (DnleH1) and tested its ability to suppress the
host IL-8 secretion. We did not detect any apparent difference in
effect between the wild type and DnleH1 (see Fig. S8). Therefore,
the use of the EPEC mutant series not only helped us narrow
down the list of candidate effectors substantially, but also, in
conjugation with the TOB02 system, allowed us to identify NleC
as a novel anti-inflammatory non-LEE effector.
Since IL-8 production is dependent on NF-kB activation, we
examined the NF-kB signaling pathway to understand the
mechanism of the NleC-dependent anti-inflammatory effect. We
found that cells infected with NleC-expressing bacteria had
markedly reduced active (phosphorylated) p65 as well as total
p65, and that this reduction was due to the cleavage of p65 by
NleC and the degradation of the remaining p65 fragments by
Figure 6. Schematic diagram illustrating the modes of action of
NleC and NleE in host NF-kB suppression. Detection of PAMPs by
cell surface receptors triggers the onset of the NF-kB signaling cascade,
leading to a chain of events involving protein modifications and
degradations; ultimately, activated p65/p50 NF-kBs enter the nucleus to
transcribe various inflammatory genes, including IL-8. EPEC/EHEC
utilizes two distinct T3SS-dependent non-LEE effectors to subdue this
response. This is accomplished by the coordinated targeting of
upstream and downstream components of the NF-kB pathway by NleE
and NleC, respectively. NleE, by an unknown mechanism, retards the
activation of IKK, thus retaining p65/p50 in a complex with IkB. NleC
digests activated p65 and to a lesser extent the IkB-bound p65, to
decrease the amount of NF-kB available to enter the nucleus, hence
reducing the overall host response to the infection.
doi:10.1371/journal.ppat.1001231.g006
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that can cleave p65 similarly at the N-terminal region [33].
However, we showed that this cleavage event was not due to
caspase-3, because the reduction of p65 was not prevented when
the cells were pre-treated with a pan-caspase inhibitor. On the
other hand, our bioinformatic search for known domains in NleC
suggested the presence of a region (183HEIIH187) corresponding
to a known zinc protease domain. By in vitro cleavage assays, we
showed that this zinc protease domain of NleC is crucial for the
processing of p65 and that the addition of a metal ion chelating
agent, such as EDTA, abrogated the wild-type NleC function.
Furthermore, it appears that the protease activity of NleC is
selective as it could not digest p50, another common NF-kB
subunit nor IkB (see Fig. S10). This inability to digest IkB suggests
that the reduced IkB in cells infected with NleC-expressing
bacteria may be of indirect consequences. These results clearly
indicated that NleC is a metalloproteinase with an HEIIH domain
that is necessary for its activity. Furthermore, the H187Y mutant
of NleC lost its cleavage activity and the ability to suppress NF-kB
activation. Therefore, we conclude that the p65 inhibitory
function of NleC relies on this zinc protease domain.
As the NF-kB signaling pathway consists of multiple compo-
nents, pathogens have evolved multiple strategies to subvert this
system. For example, OspG and OspF of Shigella spp. respectively
inhibit the ubiquitination of IkBa and modify the epigenetic
information on the promoters of NF-kB-associated transcriptions
[35,36]. In Chlamydia, CT441 is a T3SS-secreted protease that
can cleave p65 at its C-terminal region, generating p40 and p22
fragments [37]. Whereas p22 is degraded by proteasomes, p40
appears stable and inhibits the NF-kB activity when over-
expressed [37]. Although CT441 and NleC share the same host
target, these two effectors exhibit completely different pathological
kinetics, possibly owing to differences in protease structures and
their target sequences. We are currently attempting to elucidate
the site of cleavage by NleC. Whereas NleC functions relatively
early during bacterial colonization, CT441 acts at the mid-to-late
stage of Chlamydia infection. However, since it is degraded by
proteasomes upon being generated, it is unlikely that p65-C could
exist long enough in the cell to inhibit NF-kB activity. Thus, NleC
seems to be a novel type of virulence factor/effector which is
evolved independently on these other NF-kB-targeting factors.
In our study, we showed that EHEC DnleC but not EPEC DnleC
has statistically significant relief on host IL-8 response; this
discrepancy between these two close-related pathogen may due
to differences in their infection efficiency and amount of other
translocated anti-inflammatory effectors, such as NleE or NleB.
Nevertheless, the partial preservation of IL-8 secretion in cells
infected with either the DnleC or DnleE mutant compared to its full
preservation in cells infected with a DT3SS mutant shows that
multiple bacterial effector proteins are needed for full inflamma-
tory suppression. Based on our current understanding that NleE
and NleC target different components of the NF-kB pathway, we
believed that the contributions of NleE and NleC to the immune
suppressiveness of EHEC/EPEC are additive. Indeed, when
EPEC/EHEC mutants lacking both NleC and NleE (DnleC DnleE)
were tested in the infection assay, the cells responded with a level
of IL-8 secretion that was as high as in cells infected with a DT3SS
(DescF or DescD) mutant. This near-total loss of inflammation
suppression was also seen with EPEC TOE-A4, which is deficient
in both nleC and nleE genes. These results demonstrated that
EPEC/EHEC utilizes mainly these two effectors to suppress NF-
kB activation triggered by TLR-/IL-1b pathways.
The mode of actions of NleE and NleC in NF-kB interference is
becoming clear. NleE was shown to stabilize IkB and retain p65 in
the IkB-p65 complex even after stimulation with TNF-a [25,26];
however, the precise role of NleE as a direct or indirect regulator
remains to be determined. On the other hand, NleC cleaves the N-
terminus of p65, and thereby triggers p65’s proteasomal
degradation. Not only can NleC digest free p65, but when NleC
is present in large amounts, it can also digest IkB-bound p65 (see
Fig. S9), strongly suggesting that NleC can function whether p65 is
in an inhibited or free state. However, considering NleE’s ability to
cause the retention of IkB (i.e. increasing the IkB-bound p65), we
speculate that NleC cleaves released p65 more efficiently than the
p65 bound by IkB. This is supported by our finding that little p65-
C was observed after inhibiting the proteasome activity of a wild-
type-infected cells. Since the expression of NleC in the
reconstituted or complemented TOE-A4 strains showed a similar
competency to reduce NF-kB activity as the strain expressing
NleE, NleC is a potentially efficient inhibitor of NF-kB activation.
Thus, in the wild-type pathogen, NleC, functioning downstream of
NleE, may act by preferentially targeting and decreasing the
number of active p65 molecules released by activated IKK that
escapes the NleE inhibition (Fig. 6).
In our study, we did not identify NleB. As proposed by Nadler
et al., NleB functions as an accessory factor to enhance
inflammatory suppression of NleE in infected cells that were
challenged by TNF-a [25]; and Newton et al. further demonstrated
that NleB could also act independently to suppress TNF-a but not
IL-1b induced activation of NF-kB [26]. Based on their studies, it
has been suggested that NleE works either directly or indirectly
targeting the activation of IKK complex and IkB degradation and
that NleB interferes the upstream components of TNF-a signaling
pathway. The likely explanation for our inability to identify NleB
may due to the use of different stimulant than theirs, i.e. the heat-
killed bacteria, to provoke the second inflammatory response
following bacterial infection of HeLa cells. As HKE contain
bacterial compounds, such as LPS, flagellin, unmethylated
bacterial DNA, and RNA, these mainly trigger the activation of
NF-kB via TLR-/IL-1b associated pathways. Therefore, the use of
TNF-a in our screenings will likely yield similar results as
presented by Nadler et. al and Newton et al. [25,26]. Nevertheless,
as epithelial cells first come in contact with antigens of bacterial
components at the onset of infection, the anti-inflammatory NleE
and NleC at the level of IKK/IkB/NF-kB cascade are important
for executing successful infection by EPEC/EHEC.
Several studies have examined the in vivo role of nleC using
animal models and found no clear evidence showing the necessity
of NleC in the bacterial colonization [38,39]. As shown in our in
vitro experiments, deletion of nleC gene alone shows only little or no
difference in suppression of inflammatory response. This explains
the reason of no apparent effect of nleC deletion in colonization in
animal models. Although we are yet to provide in vivo evidence of
DnleC DnleE double mutant, it is speculated that this mutant would
be highly attenuated and causes early elimination by the host due
to the increase of recruited immune cells to the sites of infection.
In conclusion, we showed that NleC negatively modulates the
host NF-kB activity by the direct enzymatic digestion of p65. We
also demonstrated that NleE and NleC function in concert to
interfere with the NF-kB pathway, and that these two molecules
are responsible for anti-inflammatory effect of EPEC/EHEC. The
presence of alternative factors for modulating the NF-kB
activation pathway in EPEC/EHEC indicates that the manipu-
lation of cell signaling must be important for successful infection.
The outcome of the inflammatory response to infection depends
on multiple factors contributed by both the host and the pathogen.
Our study showing how NleE and NleC interfere with the host
innate immune response not only illustrates the importance of the
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tion, but also broadens our understanding of the intricate interplay
between pathogen and host.
Materials and Methods
Bacterial strains, plasmids, cell culture, and
oligonucleotides
The bacterial strains and plasmids used in this study are
described in Table S1. Primers used for cloning are described in
Table S2. DNA fragments containing nleC (ECs0847), nleE
(ECs3858), espL2 (ECs3855), and nleB1 (ECs3857) were amplified
directly by PCR from EHEC Sakai chromosomal DNA (Accession
No. NC_002695). The PCR products were subcloned into the
pHA-CTC plasmid (Table S1), resulting in pHA-NleC, pHA-
NleE, pHA-EspL, and pHA-NleB. The NleC (ECs0847) PCR
fragment was also subcloned into pGEM-T (Promega), pEGFP-C1
(Clontech), and pGEX-6P (GE Healthcare) to yield pGEM-T-
NleC, pEGFP-NleC, and pGEX-6P-NleC. For the site-directed
mutagenesis generating H187Y in NleC, pGEM-T-NleC was used
as the template and amplified with primers designed to change the
second histidine to tyrosine, yielding pGEM-T-NleCmut. The
NleCmut fragment was excised and cloned into pGEX-6P to
obtain pGEX-6P-NleCmut. The same fragment was also sub-
cloned into pHA-CTC to generate pHA-NleCmut. To construct
pET21A-RelA, RelA was excised from pEv3s-T7-RelA (obtained
through Addgene, plasmid # 21984) and cloned into the pET21A
plasmid. The DNA sequences were verified by sequencing. The
primers used are listed in Table S2. The human cervical cancer
cell line HeLa was maintained in MEM (Sigma) supplemented
with 10% FCS (Sigma) and 0.1 mM non-essential amino acids
(Invitrogen). Request for EPEC strains with a series of deletion and
recombinant E. coli K12 strain harboring LEE and bfp (TOB01
and TOB02) should be sent to Tetsuya Hayashi of University of
Miyazaki.
Construction of mutants derived from strain E2348/69
We constructed a series of mutants from EPEC strain E2348/69
(Table S1) as described previously by Sekiya et al. (2001) [40] with
some modifications. For example, to construct an nleC deletion
mutant (strain TOE-S1), we amplified upstream and downstream
regions of the nleC genes (about 700-bp each and including a short
sequence encoding the N- or C-terminal part of the protein) by
PCR using the nleC_B1F (59-aaaaagcaggctTCTATCGGGAA-
GATGTTGA-39)/nleC_B1R (59-TGCAAAGACGAATCATCG-
CATGTTTATATCTAATACCCT-39) and the nleC_B2F (59-
CGATGATTCGTCTTTGCA-39)/nleC_B2R (59-agaaagctgggt-
GATTCAATAGCATTCAGGAG-39) primer pairs, respectively.
As the nleC_B1R primer contained an 18-base sequence
complementary to the nleC_B2F primer sequence (underlined),
the resulting two PCR products shared an identical 18-base
sequence at their right and left ends. By the joint-PCR method
[41] using the two PCR products as a template and the adapt-F
(59-GGGGACAAGTTTGTACAaaaaagcaggct-39)/adapt-R (59-
GGGGACCACTTTGTACAagaaagctgggt-39) primer pair, we
obtained a chimeric PCR product (referred to as DnleC fragment)
consisting of the upstream and downstream sequences of the nleC
gene. At this stage, an in-frame deletion was introduced into the
target gene. Using the adaptor sequences in the adapt-F and -R
primers (indicated by lower-case letters), we cloned the DnleC
fragment into the pDONR201 entry vector by BP clonase II
(Gateway cloning system: Invitrogen). The DnleC fragment-
containing pDONR201 derivative and the Not1/NcoI double
digested pABB-CRS2 vector were incubated with LR clonase II
(Invitrogen) to transfer the DnleC fragment from pDONR201 to
pABB-CRS2 (a R6K-derived positive suicide vector). The DnleC
fragment-containing pABB-CRS2 derivative was introduced into
E. coli SM10lpir and then transferred to strain E2348/69 by
conjugation. The transductants were first screened on M9
minimum plates containing 0.8% glucose (host marker) and
ampicillin (Ap; 50 mg/ml) to obtain clones in which the pABB-
CRS2 derivative was integrated into the targeted chromosomal
region of E2348/69. These clones were grown on LB plates
containing 5% sucrose to obtain clones in which the pABB-CRS2
plasmid was eliminated by homologous recombination. Finally,
among the Ap-sensitive and sucrose-resistant clones, we screened
for clones that contained an in-frame deletion in the nleC gene by
PCR and sequencing analysis using the nleC_ckF/nleC_ckR
primers. Other mutants were also constructed from E2348/69 or
its derivatives by the same method using the primers listed in
Table S2. Since multiple T3SS effector genes are present in a
cluster on many of the prophages (PPs) and integrative elements
(IEs) in E2348/69, we deleted these gene clusters en bloc (strains
TOEA1 to TOEA7).
Construction of strains TOB01 and TOB02
A fosmid library of EPEC strain B171-8 was constructed using
the CopyControl Fosmid Library Production Kit (Epicentre,
Madison, WI), as described previously [10]. Fosmid clones
containing part or all of the LEE element were screened by
PCR using the eae gene-specific primers (SK1 and SK2 in Table
S2). The end sequences of all the eae-positive clones were
determined using the FosF and FosR primers (Table S2), to select
a clone containing the entire LEE element of B171-8 (referred to
as pTOK-02). We then introduced a plasmid named pTOK-01,
which contained the bfp operon and the perA-C locus, encoding the
genes for bundle forming pilus biosynthesis and a positive
regulator (perC) for LEE gene expression, respectively, into an
EPI300-T1-derivative containing pTOK-02, to obtain strain
TOB02. To construct plasmid pTOK-01, we purified the pB171
plasmid from B171-8 using the Qiagen Plasmid Midi kit (Qiagen,
Tokyo, Japan) and digested it with SmaI. A 22-kb fragment
containing the bfp operon and the perA-C locus was separated by
Pulsed-field gel electrophoresis (PFGE), extracted from the PFGE
gel using beta-agarase I (Nippon Gene Co., LTD, Tokyo, Japan),
and cloned into the EcoRV site of pWKS130 [42] using the BKL
kit (Takara Bio Inc., Shiga, Japan). The recombinant plasmid
(pTOK-01) was introduced into E. coli strain DH10B (Electro-
comp GeneHogs E. coli DH10B; Invitrogen) by electroporation.
Finally, the pTOK-01 plasmid was purified using the QIAprep
Spin Miniprep kit (Qiagen) and used to construct strain TOB02,
described above. Strain TOB01 was constructed by introducing a
pCC1FOS fosmid vector (constructed by self-ligation) and the
pTOK-01 plasmid into E. coli strain EPI300-T1 by electropora-
tion. More details of the genetic structures of the inserted
fragments in the pTOK-01 and pTOK-02 plasmids are shown
in Figure S1.
Secretion assay
TOB02/HA and TOB02/nleC-HA were cultured in Luria-
Bertani broth overnight with constant agitation at 37uC. Bacterial
cultures at stationary phase were diluted 100-fold in serum-free
DMEM (Sigma) and cultured with 1206 rpm agitation at 37uC
until the O.D600 reached 1.0. The bacterial cultures were
separated into the cell pellet (whole cell) and the culture
supernatant (supernatant) fractions by centrifugation at
8,000 rpm. The supernatant was filtered (pore size, 0.22 mM)
and concentrated by the addition of trichloroacetic acid (Sigma)
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0.05%, respectively. The precipitates were re-dissolved in acetone
(Wako) and centrifuged. Finally, after removing the acetone, the
residual precipitates were dissolved in 26 SDS sampler buffer.
The whole cells were also lysed with 26 SDS sampler buffer
(100 ml per O.D600 unit of original culture).
IL-8 ELISA
HeLa cells were seeded at a density of 2610
5 cells/well in 24-
well plates. The next day, overnight-grown bacteria were
inoculated into serum-free DMEM and shaken for 2 hrs at 37uC
(Pre-activation). During the pre-activation period, the cell medium
was changed to serum-free DMEM, and the cells were cultured at
37uC, 5%CO2 until the beginning of infection. The cells were
subjected to bacterial infection at moi (multiplicity of infection) of
100 for 3–4 hours. Infection was terminated by washing the cells
with PBS to remove non-adherent bacteria, and the medium was
replaced with fresh DMEM containing gentamicin (0.1 mg/ml)
and HKE (heat-killed E. coli) at concentration of 10
8 bacteria/ml.
The cells were further cultured for 8 to 12 hours, and the medium
was collected for the analysis of IL-8 by ELISA, performed
according to the manufacturer’s protocol (Thermo Scientific). All
the experiments were performed in triplicate and repeated three
times. Student’s t-test was used to calculate the significance.
SEAP reporter assay
HeLa cells were first seeded at 1610
5/well in 24-well plates one
day prior to the transfection. The pNFKB-SEAP reporter plasmid
(Clonetech; containing the kB-binding element and SEAP reporter
gene) and pGL4-13 control luciferase plasmid (Promega) were
transfected using Lipofectamine 2000 (invitrogen), according to the
manufacturer’s protocol. Forty-eight hours after transfection, the cells
were infected as described above for the IL-8 ELISA, except that at
the end of stimulation, the cell medium and lysates were collected and
assayed for reporter activity. SEAP (for NF-kB activity) and
Luciferase (transfection control) were analyzed using the Great
EscApe SEAP Fluorescence Detection kit (Clontech) and ONE-Glo
luciferase assay system (Promega), respectively. The NF-kB activities
were normalized using the luciferase reporter. For the EGFP-nleC
SEAP/Luciferase assay, pNFKB-SEAP and pGL4-13, pEGFP-C1,
or pEGFP-NleC were co-transfected into HeLa cells. Forty-eight
hours later, the cell medium was changed to serum-free DMEM for
2 hours. The cells were then stimulated with HKE for 7 hours. The
SEAP and Luciferase activity were measured as described above. All
experiments were performed in triplicate and repeated three times.
The student’s t-test was used to calculate the significance.
In vitro cleavage assay
p65, GST, GST-NleC, and GST-NleCmut were expressed by
bacteria. p65 was purified by Dynabeads (Invitrogen) conjugated to
anti-p65 antibodies (ab7970, Abcam); GST, GST-NleC, and GST-
NleCmut were purified by GST sepharose beads (GE Healthcare).
For the in vitro cleavage assay, p65 (50 nM) was mixed with GST
(0.3 nM), GST-NleC (0.3 nM), or GST-NleCmut (0.3 nM) in a
final volume of 20 ml of reaction buffer (10 mM Tris-HCl pH 7.4,
150 mM NaCl, 0.5 mM DTT, 2.5 mM CaCl2, and 0.5 mM
MgCl2, 0.5 nM ZnCl2). The reaction mixtures were incubated at
25uC for 8 hours. In some samples, EDTA was added to the
reaction buffer at final concentration of 10 mM.
Immunoblotting
Unless otherwise specified, the infected or transfected HeLa
cells were washed twice with ice-cold PBS, then directly lysed with
26 SDS sampler buffer. The lysates were sonicated briefly to
reduce the viscosity of the genomic DNA. For cell fractionation,
PBS washed cells were pelleted, resuspended in Buffer A (10 mM
HEPES pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT,
0.05% Triton X-100 and 16 protease inhibitor cocktail), and
centrifuged. The supernatant was collected as the cytoplasmic
fraction. Then the remaining pellet was washed twice with buffer
A and re-suspended in Buffer B (300 mM NaCl, 15 mM HEPES
pH 7.9, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 26%
glycerol (v/v)). Samples were sonicated and left on ice for 30 min
before being centrifuged. The resulting supernatant containing the
nuclear content was collected. For western blotting, a standard
protocol was used. Anti-p65 N-term (# 4764, Cell Signaling
Technology), anti-phospho-p65 (# 3033, Cell Signaling Technol-
ogy), anti-IkBa (# 4814, Cell Signaling Technology), anti-Lamin
A/C (# 2032, Cell Signaling Technology), anti-p65 C-term
(ab7970, Abcam), and anti-a-tubulin (Clone B-5-1-2, Sigma)
antibodies were used.
Immunofluorescence staining
HeLa cells were seeded at density of 1610
5 cells/cm
2 on cover
glasses one day prior to the experiment. On the day of experiment,
culture media were exchanged with serum free DMEM and cells
were subjected to pre-activated bacteria at m.o.i of 100. Infection
was allowed to proceed for 3 hours and was terminated by
washing cells with PBS to remove non-adherent bacteria. Cells
were fixed with 4% paraformaldehyde and permeabilized with
0.5% Triton X-100 in PBS. Following the blocking with 5% BSA
in PBS, cells were stained with anti-HA (Bethyl Laboratories, Inc.,
Montgomery, TX, USA), Rhodamin-Phallodin (Wako, Japan),
and DAPI (Sigma-Aldrich, Japan). Anti-rabbit-FITC (against anti-
HA antibody) was used as the secondary antibody. Immunoflu-
orescence images were taken using BioRad Radiance2100
confocal microscope.
Supporting Information
Table S1 Bacterial strains and plasmids used in this study.
Found at: doi:10.1371/journal.ppat.1001231.s001 (0.05 MB PDF)
Table S2 Primers and oligonucleotides used in this study.
Found at: doi:10.1371/journal.ppat.1001231.s002 (0.02 MB PDF)
Figure S1 Gene organizations of the inserted fragments in
pTOK-01 and pTOK-02.
Found at: doi:10.1371/journal.ppat.1001231.s003 (0.73 MB PDF)
Figure S2 Comparison of Tir translocation efficiency between
wild type EPEC and reconstructed strain TOB02. HeLa cells were
infected by m.o.i of 100 of pre-activated wild type EPEC, DescF
(T3SS defective mutant), and TOB02 for 2 hours. Cells were
rinsed with cold PBS twice to remove the non-adherent bacteria,
scrapped and collected in the presence of sonication buffer
(50 mM NaCl, 50 mM Tris pH 7.9, 10% sucrose (w/v), 2 mM
EDTA, 0.4 mM Na3VO4,1 6 protease inhibitor cocktail).
Samples were sonicated for 3 sec to disrupt mammalian but not
bacterial membrane. Then ultracentrifugation was applied at
45,000 rpm, 15 min. at 4uC. The pellet was washed once with
sonication buffer and resuspended in the lysis buffer (50 mM
NaCl, 50 mM Tris pH 7.9, 10% sucrose (w/v), 2 mM EDTA,
0.4 mM Na3VO4, 0.5% Triton-X, and 16 protease inhibitor
cocktail). Lysates were subjected to second round of ultracentri-
fugation (45,000 rpm, 5 min. at 4uC). Finally the supernatant
which contained the membrane fraction (host cell membrane) was
collected. For the bacterial whole cell (bacteria), the bacterial pellet
from 1 ml of the activation culture was lysed with 26SDS sampler
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antibody. This experiment was repeated three times and the
representative blot is shown.
Found at: doi:10.1371/journal.ppat.1001231.s004 (0.08 MB PDF)
Figure S3 TOB02/nleC-HA is able to secret NleC-HA via a
reconstituted T3SS. Overnight-grown TOB02/HA and TOB02/
nleC-HA were inoculated into DMEM for the secretion assay.
When the bacterial growth reached O.D600 ,1.0, the supernatant
and bacterial pellet were separated by centrifugation and subjected
to immunoblot analysis. An anti-HA antibody was used to detect
the expression of NleC-HA, and anti-DnaK was used to verify that
the supernatant was free of whole-bacteria contaminants.
Found at: doi:10.1371/journal.ppat.1001231.s005 (0.09 MB PDF)
Figure S4 NleC-HA can be secreted by the endogenous T3SS in
EHEC O157:H7, and localizes to the cytoplasm. The NleC-HA-
expressing wild-type EHEC O157:H7 was used to infect HeLa
cells. After 4 hours of infection, the cells were washed with PBS to
remove non-adherent bacteria, and fixed with 4% PFA (parafor-
maldehyde). The cells were then stained with anti-HA (FITC) and
with DAPI to label DNA. Photographs and the xz-axis views were
taken using a Radiance 2100 confocal laser scanning microscope
(Bio-Rad).
Found at: doi:10.1371/journal.ppat.1001231.s006 (0.34 MB PDF)
Figure S5 The degradation of p65-C is dependent on the
proteosome. HeLa cells were first pretreated with either DMSO,
or MG132 (5 mM), or lactacystin (10 mM) for 2 hours. Pre-
activated TOB02/HA or TOB02/nleC-HA was used to infect the
cells for another 2 hours. The cells were rinsed with PBS to
remove non-adherent bacteria and lysed directly by addition of
SDS sampler buffer. Samples were analyzed using anti-p65 (C-
term) and anti-alpha-tubulin antibodies.
Found at: doi:10.1371/journal.ppat.1001231.s007 (0.08 MB PDF)
Figure S6 Caspase-3 is not involved in p65 cleavage during the
TOBA2/nleC-HA bacterial infection. HeLa cells were first
pretreated with either DMSO or z-VAD-fmk (5 mM) for 2 hours.
Pre-activated TOB02/HA or TOB02/nleC-HA was then used to
infect the cells for another 2 hours. The cells were rinsed with PBS
to remove non-adherent bacteria and lysed by the direct addition
of SDS sampler buffer. The cell samples were analyzed using anti-
p65 (C-term.) and anti-Lamin A/C antibodies by immunoblotting.
Found at: doi:10.1371/journal.ppat.1001231.s008 (0.10 MB PDF)
Figure S7 Generation of p65-C in native wild-type EPEC. HeLa
cells pretreated with either DMSO or MG132 (5 mM) were
infected with EPEC of wild type (WT), DescF, DnleC, and DnleC/
nleC for 2 hours. Non-adherent bacteria were removed by washing
cells with PBS. Cells were then directly lysed with sample buffer
and analyzed by anti-p65 (N-term), anti-p65 (C-term), and a-
tubulin (loading control) antibodies. Short and Long exposure of
the membrane were taken. p65-C fragment is indicated by
arrowheads. This experiment was repeated three times and one of
the representative blot is shown.
Found at: doi:10.1371/journal.ppat.1001231.s009 (0.11 MB PDF)
Figure S8 EHEC DnleH1 does not alleviate the immune
suppression. HeLa cells were infected with pre-activated wild-
type, or the DescF, DnleH1, and DnleH2 isogenic mutants of EHEC.
After 4 hours of infection, the cell culture medium was replaced
with fresh DMEM containing gentamicin (0.1 mg/ml) and HKE
(1/10 vol.). The cells were further cultured for 8 hours, and the
medium was then collected for IL-8 analysis by ELISA. Similar
experiments were performed in triplicate and repeated three times.
Student’s t-test was used, and p,0.05 was considered significant.
Found at: doi:10.1371/journal.ppat.1001231.s010 (0.04 MB PDF)
Figure S9 IkBa-associated p65 can be processed by NleC. HeLa
cells pretreated with either DMSO or MG132 (5 mM) were
infected with wild-type, DnleC, or DnleC/pnleC-HA of EPEC for
2 hours. At the end of infection, the HeLa cells were rinsed with
PBS to remove non-adherent bacteria, and lysed with NET150 on
ice. The cytoplasmic fraction was immunoprecipitated with an
anti-IkBa antibody, and the pull-down products were analyzed
using an anti-p65 (C-term.) antibody by immunoblotting.
Found at: doi:10.1371/journal.ppat.1001231.s011 (0.09 MB PDF)
Figure S10 NleC does not cleave p50 nor IkB in vitro. Cell
lysates were prepared from unstimulated HeLa cells. The lysates
were then mixed with GST, GST-NleCwt, and GST-NleCmut in
vitro and were incubated at 25uC for 8 hours. The reactions were
terminated by direct addition of 26sample buffer. Samples were
analyzed by immunoblotting using anti-p50, anti-IkBa, and anti-
tubulin antibodies. This experiment was repeated three times and
the representative blot is shown.
Found at: doi:10.1371/journal.ppat.1001231.s012 (0.07 MB PDF)
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